Advertisement

Topics

European Society for Medical Oncology (ESMO) - White Blood Cell Count Predicts Response to Lung Cancer Immunotherapy

14:27 EDT 4 May 2017 | PR Newswire
This article has expired, however you can still download the PDF.
Preview:
GENEVA, May 5, 2017 /PRNewswire/ -- White blood cell counts can predict whether or not lung cancer patients will benefit from immunotherapy, according to research presented at the European Lung Cancer Conference (ELCC). "Immune checkpoint inhibitor...

Other Sources for this Article

NEXT ARTICLE

More From BioPortfolio on "European Society for Medical Oncology (ESMO) - White Blood Cell Count Predicts Response to Lung Cancer Immunotherapy"

Quick Search
Advertisement
 

Relevant Topic

Lung Cancer
Lung cancer is the uncontrolled cell growth in tissues of the lung. Originating in the lungs, this growth may invade adjacent tissues and infiltrate beyond the lungs. Lung cancer, the most common cause of cancer-related death in men and women, is respons...